TARGETGENE

DEVELOPING THE WORLD’S
BEST THERAPEUTIC GENOME
EDITING PLATFORM

Find out how TargetGene will change the world

we aim to cure

Cancer by modifying cells from the patient’s own immune system.

Genetic and heritable diseases by replacing defective genes. 
First focusing on orphan disease.

Autoimmune disorders by removing the autoantigen or modulating the immune system.

THE PATIENT'S OWN CELLS ARE GENETICALLY MODIFIED

TargetGene’s exquisitely precise and flexible TGEE platform enables development ​of safe and efficient genome editing treatments.

Flexibility allows rapid development and facilitates personalized medicine.

Competing systems lack the safety and flexibility necessary for therapeutic use. 

TARGETGENE’S TGEE PLATFORM IS DESIGNED TO OVERCOME OFF-TARGET CLEAVAGE WHICH IS THE MOST SERIOUS PROBLEM CURRENTLY IMPEDING THERAPEUTIC GENOME EDITING.

Close Menu